Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
The latest announcement is out from Evogene ( (EVGN) ).
On February 12, 2025, Evogene Ltd. announced that its shareholders approved a proposal at a special general meeting, following an adjournment from its original date. This decision aligns with the Israeli Companies Law and the company’s articles of association, marking a significant step in the company’s governance processes.
More about Evogene
Evogene Ltd. is a biotechnology company based in Israel, focusing on the development of products for life science markets, including agriculture, human health, and industrial applications.
YTD Price Performance: -23.40%
Average Trading Volume: 58,991
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $8.37M
For a thorough assessment of EVGN stock, go to TipRanks’ Stock Analysis page.
